Indicator Explorer

Indicator description
Indicator: Children who took any ACT
Measure: Percent
Definition: Percentage of children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs who took any artemisinin-based combination therapy. Note: In some countries, ACT is colloquially referred to as amodiaquine by survey respondents, making it difficult to distinguish the single drug (amodiaquine) from the combination therapy (ACTs). This confusion can impact the interpretation of the indicator, making it difficult to analyze trends over time. This indicator should be interpreted with caution. See also ML_AMLD_C_AMQ.
Denominator: Children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs
Group: Type of antimalarial drugs used
Universe: Children
Type: Indicator
Decimals: 1
Indicator ID: ML_AMLD_C_ACT
Indicator description
Indicator: Children who took Quinine
Measure: Percent
Definition: Percentage of children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs who took Quinine
Denominator: Children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs
Group: Type of antimalarial drugs used
Universe: Children
Type: Indicator
Decimals: 1
Indicator ID: ML_AMLD_C_QNN
Indicator description
Indicator: Children who took SP/Fansidar
Measure: Percent
Definition: Percentage of children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs who took SP/Fansidar
Denominator: Children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs
Group: Type of antimalarial drugs used
Universe: Children
Type: Indicator
Decimals: 1
Indicator ID: ML_AMLD_C_SPF
Indicator description
Indicator: Children who took Chloroquine
Measure: Percent
Definition: Percentage of children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs who took Chloroquine
Denominator: Children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs
Group: Type of antimalarial drugs used
Universe: Children
Type: Indicator
Decimals: 1
Indicator ID: ML_AMLD_C_CHL
Indicator description
Indicator: Children who took Amodiaquine
Measure: Percent
Definition: Percentage of children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs who took Amodiaquine. Note: In some countries, ACT is colloquially referred to as amodiaquine by survey respondents, making it difficult to distinguish the single drug (amodiaquine) from the combination therapy (ACTs). This confusion can impact the interpretation of the indicator, making it difficult to analyze trends over time. This indicator should be interpreted with caution. See also ML_AMLD_C_ACT.
Denominator: Children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs
Group: Type of antimalarial drugs used
Universe: Children
Type: Indicator
Decimals: 1
Indicator ID: ML_AMLD_C_AMQ
Indicator description
Indicator: Children who took Artesunate mono therapy
Measure: Percent
Definition: Percentage of children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs who took Artesunate mono therapy
Denominator: Children under age 5 with fever in the two weeks preceding the survey that received any anti-malarial drugs
Group: Type of antimalarial drugs used
Universe: Children
Type: Indicator
Decimals: 1
Indicator ID: ML_AMLD_C_ART
Indicator description
Indicator: Children who took another antimalarial
Measure: Percent
Definition: Percentage of children under age five with fever in the two weeks preceding the survey and received any anti-malarial drugs who took another antimalarial
Denominator: Children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs
Group: Type of antimalarial drugs used
Universe: Children
Type: Indicator
Decimals: 1
Indicator ID: ML_AMLD_C_OAM
DHS Quickstats Indicators

  Indicator Name Indicator Definition Indicator Denominator  
Children who took any ACT Percentage of children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs who took any artemisinin-based combination therapy. Note: In some countries, ACT is colloquially referred to as amodiaquine by survey respondents, making it difficult to distinguish the single drug (amodiaquine) from the combination therapy (ACTs). This confusion can impact the interpretation of the indicator, making it difficult to analyze trends over time. This indicator should be interpreted with caution. See also ML_AMLD_C_AMQ. Children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs (C)
Children who took Quinine Percentage of children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs who took Quinine Children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs (C)
Children who took SP/Fansidar Percentage of children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs who took SP/Fansidar Children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs (C)
Children who took Chloroquine Percentage of children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs who took Chloroquine Children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs (C)
Children who took Amodiaquine Percentage of children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs who took Amodiaquine. Note: In some countries, ACT is colloquially referred to as amodiaquine by survey respondents, making it difficult to distinguish the single drug (amodiaquine) from the combination therapy (ACTs). This confusion can impact the interpretation of the indicator, making it difficult to analyze trends over time. This indicator should be interpreted with caution. See also ML_AMLD_C_ACT. Children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs (C)
Children who took Artesunate mono therapy Percentage of children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs who took Artesunate mono therapy Children under age 5 with fever in the two weeks preceding the survey that received any anti-malarial drugs (C)
Children who took another antimalarial Percentage of children under age five with fever in the two weeks preceding the survey and received any anti-malarial drugs who took another antimalarial Children under age five with fever in the two weeks preceding the survey that received any anti-malarial drugs (C)